Come and join us across the globe
Vancouver, Canada– Evasc Neurovascular is thrilled to announce the successful use of the eCLIPs Short Landing Zone device in treating all Anterior Communicating Artery (ACOM) and Middle Cerebral Artery (MCA) bifurcation aneurysms. The first successful case using this pioneering device was performed by Dr. Jensen at Aarhus University Hospital, Denmark. Alongside this clinical milestone, we are pleased to announce that the eCLIPs Short Landing Zone device has received CE/MDR (Conformité Européenne/Medical Device Regulation) approval, underscoring its safety and efficacy for use across the European Union.
Dr. Jensen performed the groundbreaking procedure, achieving excellent results and setting a new standard in the treatment of complex intracranial aneurysms. The eCLIPs Short Landing Zone device, designed for stable aligning and orientation of the spine, offers a paramount solution for addressing bifurcation aneurysms in both ACOM and MCA regions. Its innovative design allows for enhanced navigation and deployment, thus ensuring optimal outcomes for patients.
"We are extremely proud of this significant achievement. Now we have an eCLIPs device for every bifurcation aneurysm, including BT, CT, ACOM, and MCA. We expect a potentially disruptive impact on the treatment of bifurcation aneurysms. The majority of all aneurysms are, after all, ACOM and MCA aneurysms," said Wieger Kaptein, a representative of Evasc Neurovascular.
About Evasc Neurovascular
Evasc Neurovascular, based in Vancouver, Canada, is a trailblazer in the development and provision of advanced neurovascular technologies. Renowned for its dedication to research, innovation, and patient care, the company stands as a leader in the treatment of wide neck bifurcation
Contact
For more information about Evasc Neurovascular please visit: www.evasc.com.